Cipta Sarana Medika Tbk. vs Multi Bintang Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Multi Bintang Indonesia Tbk. trades at Rp6,975 (market cap 14.85T, 42.2K 24h volume). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 92.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 42.2K). Which is the better fit depends on your goals.
| DKHH | MLBI | |
|---|---|---|
Market Cap | 160.67B | 14.85T |
Volume | 14.05M | 42.2K |
Lot | 140.49K | 422 |
Turnover | 899.67M | 293.55M |
Average Price | 64.04 | 6,956.22 |
Value | 899.67M | 293.55M |
Indicative Equilibrium Price | 64 | 6,975 |
Indicative Equilibrium Volume | 100 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Read more on MLBI →